A Study of Abatacept in Patients With Active Ulcerative Colitis

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active ulcerative colitis in patients who have not had an adequate response to other therapies. The safety of this treatment will also be studied

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Abatacept

Criteria

Inclusion Criteria:

• Men or women 18 years or older

• Ulcerative colitis for at lease 3 months

• Moderate to severe active ulcerative colitis

• Inadequate response or intolerance to standard ulcerative colitis treatment